FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014828564> ?p ?o ?g. }

• W2014828564 endingPage "88" @default.
• W2014828564 startingPage "81" @default.
• W2014828564 abstract "The aim of this study is to assess the effectiveness of Radiosynovectomy (RSV) using (177)Lu-labeled hydroxyapatite ((177)Lu-HA) in the treatment of painful synovitis and recurrent joint effusion of knee joints in rheumatoid arthritis (RA). Ten patients, diagnosed with RA and suffering from chronic painful resistant synovitis of the knee joints were referred for RSV. The joints were treated with 333 ± 46 MBq of (177)Lu-HA particles administered intra-articularly. Monitoring of activity distribution was performed by static imaging of knee joint and whole-body gamma imaging. The patients were evaluated clinically before RSV and at 6 months after the treatment by considering the pain improvement from baseline values in terms of a 100-point visual analog scale (VAS), the improvement of knee flexibility and the pain remission during the night. RSV response was classified as poor (VAS < 25), fair (VAS ≥ 25-50), good (VAS ≥ 50-75) and excellent (VAS ≥ 75), with excellent and good results considered to be success, while fair and poor as failure and also by range of motion. Three phase bone scan (BS) was repeated after 6 months and changes in the second phase of BS3 were assessed visually, using a four-degree scale and in the third phase, semiquantitatively with J/B ratio to see the response. Biochemical analysis of C-reactive protein (CRP) and fibrinogen was repeated after 48 h, 4 and 24 weeks. In all 10 patients, no leakage of administered activity to nontarget organs was visible in the whole-body scan. Static scans of the joint at 1 month revealed complete retention of (177)Lu-HA in the joints. All patients showed decreased joint swelling and pains, resulting in increased joint motion after 6 months. The percentage of VAS improvement from baseline values was 79.5 ± 20.0% 6 months after RS and found to be significantly related to patients' age (P = 0.01) and duration of the disease (P = 0.03). Knees with Steinbrocker's Grades 0 and I responded better than those with more advanced changes (Steinbrocker's Grades III and IV) in terms of VAS improvement (75% vs. 45.8%) (P < 0.001). The overall success rate (VAS ≥ 50) was 80%. Remission of pain during the night was achieved in 100%, and knee flexibility was improved in 80%. The changes in the blood pool phase before RSV were 3.2 ± 0.7 and after the therapy 1.4 ± 0.7 (P < 0.001). The J/B ratio was: Before RSV 2.4 ± 0.3; after treatment 1.0 ± 0.2 (P < 0.05). CRP concentration 4 and 24 weeks after the therapy was significantly lower than before treatment. The fibrinogen level was not different before and after RSV. RSV side-effects assessed for the whole follow-up period were minor and not significant. RSV with (177)Lu-HA was safe and effective in patients with knee joint chronic painful synovitis of rheumatoid origin. It exhibited significant therapeutic effect after 6 months follow-up period with no significant side-effects. The preliminary investigations reveal that (177)Lu-labeled HA particles hold considerable promise as a cost-effective agent for RSV. More elaborate and controlled clinical trials are necessary to evaluate the therapeutic efficacy and safety of the agent compared with the treatment with other radionuclides and glucocorticosteroids." @default.
• W2014828564 created "2016-06-24" @default.
• W2014828564 creator A5014377814 @default.
• W2014828564 creator A5022053889 @default.
• W2014828564 creator A5024993863 @default.
• W2014828564 creator A5031322337 @default.
• W2014828564 creator A5058263313 @default.
• W2014828564 creator A5059201450 @default.
• W2014828564 creator A5064968701 @default.
• W2014828564 creator A5069519471 @default.
• W2014828564 creator A5081917957 @default.
• W2014828564 creator A5086339269 @default.
• W2014828564 date "2015-04-01" @default.
• W2014828564 modified "2023-09-26" @default.
• W2014828564 title "Radiosynovectomy of Painful Synovitis of Knee Joints Due to Rheumatoid Arthritis by Intra-Articular Administration of 177 Lu-Labeled Hydroxyapatite Particulates: First Human Study and Initial Indian Experience" @default.
• W2014828564 cites W13725933 @default.
• W2014828564 cites W1822040505 @default.
• W2014828564 cites W1835382240 @default.
• W2014828564 cites W1971583690 @default.
• W2014828564 cites W1994775441 @default.
• W2014828564 cites W1995600944 @default.
• W2014828564 cites W2012223968 @default.
• W2014828564 cites W2030479187 @default.
• W2014828564 cites W2041809349 @default.
• W2014828564 cites W2042634642 @default.
• W2014828564 cites W2065031115 @default.
• W2014828564 cites W2070382160 @default.
• W2014828564 cites W2073236242 @default.
• W2014828564 cites W2088841333 @default.
• W2014828564 cites W2096593842 @default.
• W2014828564 cites W2118945736 @default.
• W2014828564 cites W2128192554 @default.
• W2014828564 cites W2135827498 @default.
• W2014828564 cites W2145551666 @default.
• W2014828564 cites W2150364916 @default.
• W2014828564 cites W2186514525 @default.
• W2014828564 cites W2188209559 @default.
• W2014828564 cites W2331627536 @default.
• W2014828564 cites W2395693609 @default.
• W2014828564 cites W2401703613 @default.
• W2014828564 cites W2403571409 @default.
• W2014828564 cites W2462238073 @default.
• W2014828564 cites W2464235818 @default.
• W2014828564 cites W3021389063 @default.
• W2014828564 cites W38242761 @default.
• W2014828564 doi "https://doi.org/10.4103/1450-1147.153908" @default.
• W2014828564 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4455177" @default.
• W2014828564 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26097417" @default.
• W2014828564 hasPublicationYear "2015" @default.
• W2014828564 type Work @default.
• W2014828564 sameAs 2014828564 @default.
• W2014828564 citedByCount "17" @default.
• W2014828564 countsByYear W20148285642016 @default.
• W2014828564 countsByYear W20148285642018 @default.
• W2014828564 countsByYear W20148285642020 @default.
• W2014828564 countsByYear W20148285642021 @default.
• W2014828564 crossrefType "journal-article" @default.
• W2014828564 hasAuthorship W2014828564A5014377814 @default.
• W2014828564 hasAuthorship W2014828564A5022053889 @default.
• W2014828564 hasAuthorship W2014828564A5024993863 @default.
• W2014828564 hasAuthorship W2014828564A5031322337 @default.
• W2014828564 hasAuthorship W2014828564A5058263313 @default.
• W2014828564 hasAuthorship W2014828564A5059201450 @default.
• W2014828564 hasAuthorship W2014828564A5064968701 @default.
• W2014828564 hasAuthorship W2014828564A5069519471 @default.
• W2014828564 hasAuthorship W2014828564A5081917957 @default.
• W2014828564 hasAuthorship W2014828564A5086339269 @default.
• W2014828564 hasBestOaLocation W20148285641 @default.
• W2014828564 hasConcept C126322002 @default.
• W2014828564 hasConcept C126838900 @default.
• W2014828564 hasConcept C141071460 @default.
• W2014828564 hasConcept C14184104 @default.
• W2014828564 hasConcept C143409427 @default.
• W2014828564 hasConcept C163430725 @default.
• W2014828564 hasConcept C2777077863 @default.
• W2014828564 hasConcept C2777575956 @default.
• W2014828564 hasConcept C2778573185 @default.
• W2014828564 hasConcept C2779244835 @default.
• W2014828564 hasConcept C2908736133 @default.
• W2014828564 hasConcept C2989005 @default.
• W2014828564 hasConcept C60465272 @default.
• W2014828564 hasConcept C71924100 @default.
• W2014828564 hasConceptScore W2014828564C126322002 @default.
• W2014828564 hasConceptScore W2014828564C126838900 @default.
• W2014828564 hasConceptScore W2014828564C141071460 @default.
• W2014828564 hasConceptScore W2014828564C14184104 @default.
• W2014828564 hasConceptScore W2014828564C143409427 @default.
• W2014828564 hasConceptScore W2014828564C163430725 @default.
• W2014828564 hasConceptScore W2014828564C2777077863 @default.
• W2014828564 hasConceptScore W2014828564C2777575956 @default.
• W2014828564 hasConceptScore W2014828564C2778573185 @default.
• W2014828564 hasConceptScore W2014828564C2779244835 @default.
• W2014828564 hasConceptScore W2014828564C2908736133 @default.
• W2014828564 hasConceptScore W2014828564C2989005 @default.
• W2014828564 hasConceptScore W2014828564C60465272 @default.
• W2014828564 hasConceptScore W2014828564C71924100 @default.
• W2014828564 hasIssue "02" @default.
• W2014828564 hasLocation W20148285641 @default.

• next